— Company formed and originally seeded by Omega Funds, Series A financing with exceptional syndicate led by Vida Ventures

— World-class leadership team led by Peter F. Lebowitz, MD, PhD, Sanjaya Singh, PhD, and Joe Erhardt, PhD, well-positioned to achieve significant clinical inflection points across multiple programs

BOSTON, July 23, 2024 — Third Arc Bio Inc., a biotech company developing multifunctional antibodies that are optimized for best-in-class T cell engagement across solid tumors and inflammatory & immunology (I&I) disease, today announced a $165 million oversubscribed Series A financing that will advance the company through clinical studies to address significant unmet needs in oncology and autoimmunity. 

The company was launched in 2022 with seed financing from Omega Funds and has since advanced multiple programs that will enter the clinic starting in early 2025. The Series A investor syndicate was led by Vida Ventures and co-led by Cormorant Asset Management and Hillhouse Investment. Omega Funds continued their strong support of the company in the Series A and additional investors include Goldman Sachs Alternatives, BVF Partners LP, funds and accounts advised by T. Rowe Price Associates, Inc., Janus Henderson Investors, funds managed by abrdn Inc., Marshall Wace, Foresite Capital, Logos Capital, Freepoint Capital Group, and AbbVie Ventures.

“With a powerful discovery engine and a stellar development team, the company is well-positioned to deliver best-in-class therapies and regimens,” said Peter Lebowitz, MD, PhD, Chief Executive Officer (CEO) of Third Arc Bio. “We are grateful for the strong support from Omega Funds and our investor syndicate, who believe in the value of our precise and targeted approach to modulating the immune response with advanced biologics.”

“Less than three years ago, we decided to help realize the scientific vision of Third Arc Bio’s founding team by pairing the latest innovation in antibody development with the pursuit of high impact targets in oncology and autoimmunity,” said Francesco Draetta, Managing Partner of Omega Funds. “We are delighted to have played a role in the company’s rapid growth since its inception. This latest oversubscribed financing reflects the hard work and progress of the talented Third Arc team and the broad interest in their approach. We are very excited to see the potential impact that these drugs could have for patients.”

“The Third Arc Bio team has an outstanding track record of developing impactful medicines, including multiple approved drugs that have redefined standard-of-care in oncology and I&I,” said Arjun Goyal, MD, Co-Founder and Managing Director of Vida Ventures. “We are tremendously excited to lead this round alongside a high-caliber syndicate of life science and strategic investors at a pivotal time for the company’s growth. With Third Arc’s leading portfolio of best-in-class biologics, multiple INDs planned for 2025, and an extraordinary team of drug developers, the company is poised to create bold new treatments leveraging T cell biology for patients globally.”

Third Arc Bio’s accomplished leadership team has collectively brought 19 drugs from discovery and development to commercialization:

• Peter F. Lebowitz, MD, PhD joined Third Arc Bio as CEO in January of 2024. Peter is a renowned industry leader with extensive drug development experience, including from his prior role as Global Head of Oncology R&D for Johnson & Johnson. Under Peter’s leadership, J&J Oncology achieved 13 major new drug approvals with first and best-in-class medicines. The innovative approach to drug development was reflected in 13 FDA Breakthrough Therapy Designations and 38 New England Journal Publications. Prior to J&J, Peter also served in multiple leadership roles at GSK including as Vice President, Global Head of Oncology Early Clinical Development and Vice President, Medical Development Leader in Late Development at GlaxoSmithKline where he successfully filed 10 Investigational New Drug applications and played a crucial role in the global registration of two oncology medicines.
• Sanjaya Singh, PhD is the founder and Chief Scientific Officer of Third Arc Bio. He is a leading expert in biotherapeutics with more than 25 years of experience. Sanjaya is a co-inventor of multiple immunology and immuno-oncology compounds, including Risankizumab (Skyrizi). Sanjaya’s industry experience includes Global Head of Janssen Biotherapeutics, Johnson & Johnson, Boehringer Ingelheim, Biotherapeutics Discovery and Tanox, Inc. (acquired by Genentech). Sanjaya is co-founder and Scientific Advisory Board member of Aliada Therapeutics.
• Joe Erhardt, PhD is the Chief Operating Officer of Third Arc Bio and is a highly experienced drug developer, having served for over 20 years in roles from early discovery through late clinical development. In his prior roles, including his most recent role as Vice President, Global Head of Oncology Discovery and External Innovation at Johnson & Johnson, Joe has had operational oversight of expansive portfolios as well as licensing and collaboration for oncology discovery and early development. Joe has delivered a significant number of internal and external candidates in discovery and clinical pipelines across a range of modalities including T cell redirection, T cell costimulation, antibody drug conjugates (ADCs), and targeted radiotherapy.

About Third Arc Bio
Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.

About Omega Funds
Founded in 2004, Omega Funds is a leading international venture capital firm that creates and invests in life sciences companies that target our world’s most urgent medical needs. Omega focuses on supporting companies through value inflection points across the full arc of innovation, from formation through clinical and commercial milestones. Omega portfolio companies have brought 50 products to market in multiple therapeutic areas, including oncology, rare diseases, precision medicine and others. Visit www.omegafunds.com for additional information.

About Vida Ventures
Vida Ventures, LLC (“Vida”) is a next-generation life sciences investment firm founded by scientists, physicians, entrepreneurs and investors, who are passionate about building and funding breakthroughs in biomedicine. Vida’s mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients. Vida currently has approximately $1.8 billion of capital commitment from blue-chip investors. Vida has offices in Los Angeles, Boston and Fort Worth and is focused on identifying groundbreaking science and building innovative companies that lead to new areas of drug discovery and development. For more information on Vida Ventures, please visit www.vidaventures.com, on LinkedIn or follow on Twitter @Vida_Ventures.

SOURCE Third Arc Bio

Investment Empowers Next Stage of Growth and Innovation for Leading Software Platform Focused on Digitizing Wealth Management Operations

HOLMDEL, N.J., July 23, 2024 — Docupace, a leading provider of software to streamline back-office operations of wealth management enterprises and financial advisors, today announced a strategic majority investment from Genstar Capital (“Genstar”), a leading private equity firm focused on investments in targeted segments of the financial services, software, industrials and healthcare industries.

“Genstar’s investment is a testament to our belief that Docupace is transforming how critical work – new account opening, client onboarding, workflow, compliance, compensation, advisor transitions, data gathering and client engagement – gets done in wealth management enterprises,” said Docupace Chief Executive Officer David Knoch. “We are excited to welcome Genstar as a strategic investor as we further improve the operational experience for clients, financial advisors, their staff, and home office team members. This recapitalization positions Docupace to continue leading the back-office revolution and to seize the substantial growth potential that lies ahead.”

This significant investment makes Genstar the majority investor of the fast-growing technology innovator. FTV Capital (“FTV”), which made a growth investment in the company in 2020, will remain a minority investor in Docupace.

“We’ve been following Docupace’s transformation for several years, and we are proud to partner with Docupace and its management team on the next chapter of growth,” said Sid Ramakrishnan, Director at Genstar Capital. “The wealth management ecosystem is highly and ever-increasingly complex, and firms need scalable operations that serve financial advisors and their clients. Docupace has a proven track record of delivering purpose-built software solutions that transform the operations of the back-office. We look forward to partnering with David and his team to advance Docupace’s platform and accelerate growth, both organically and inorganically, and to continue delivering value to clients.”

Under FTV’s ownership, Docupace has grown into the leading platform for wealth management operations. Each workday, more than 130,000 electronic documents are processed and delivered, more than 62,000 work items are completed and nearly 10,000 new client accounts are opened using Docupace products and solutions. With the acquisitions of jaccomo and PreciseFP in 2021, the company expanded its platform solutions into compensation, compliance, and digital client data gathering, respectively.

This transformation has generated significant accolades and attention. In the first half of 2024, Docupace was named Best Onboarding Product by WealthTech Americas; won gold, silver and bronze at the 2024 Stevie Awards, and was named finalist twice – Best-as-a-Service Solution at the Banking Tech USA Awards and WealthTech of the Year at the 2024 InvestmentNews Awards.

“It has been incredible to partner with David, Michael (founder) and the team on Docupace’s momentous journey of growth and transformation,” said Robert Anderson, partner at FTV Capital. “Over the last four years, we’ve built a world-class organization that has driven consistent growth and meaningfully enhanced the Docupace platform to serve an expanding client base. Docupace has become synonymous with the ‘digital back-office’ across the wealth management landscape, and we can’t wait to celebrate many more exciting milestones in the years ahead.”

Financial Technology Partners (FT Partners) served as exclusive financial advisor and Gibson Dunn served as legal counsel to Docupace. RBC Capital Markets served as financial advisor and Ropes and Gray served as legal counsel to Genstar. The transaction is expected to close in the third quarter of 2024, subject to the receipt of regulatory approvals and the satisfaction of other closing conditions. The terms of the transaction were not disclosed.

About Docupace
Docupace is a solutions provider focused on digitizing and automating operations in the financial advice and investment industry. Financial services firms use the Docupace Platform (a cloud-based, integrated software suite) to reduce back-office expenses, improve efficiency, strengthen recruiting, and enhance the experience of advisors and investors. With headquarters in Holmdel, New Jersey, Docupace is proud to serve some of the largest independent broker-dealers and registered investment advisers (RIAs) in the financial services industry.

For more information, please visit www.docupace.com.

About Genstar Capital
Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high-quality companies for over 30 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $49 billion of assets under management and targets investments focused on targeted segments of the financial services, industrials, software, and healthcare industries.

About FTV Capital
FTV Capital is a sector-focused growth equity investment firm that has raised $6.2 billion to invest in high-growth companies offering a range of innovative solutions in enterprise technology and services and financial technology and services. FTV’s experienced team leverages its domain expertise and proven track record in each of these sectors to help motivated management teams accelerate growth. FTV also provides companies with access to its Global Partner Network®, a group of the world’s leading enterprises and executives who have helped FTV portfolio companies for two decades. Founded in 1998, FTV Capital has invested in over 140 portfolio companies, including Derivative Path, EBANX, Masttro, Patra, True Potential and Vagaro, and successfully exited/partially exited companies including Centaur (acquired by Waystone Group), Enfusion, Globant, InvestCloud (recapitalized), Strata Fund Solutions (acquired by Alter Domus), Tango Card (acquired by Blackhawk Network) and VPay (acquired by Optum). FTV has offices in New York, San Francisco, Connecticut and London.

For more information, please visit www.ftvcapital.com and follow the firm on LinkedIn.

Media Contacts:

For Docupace
Ryan George
Chief Marketing Officer
[email protected]

Joseph Kuo / Donald Cutler
Haven Tower Group
[email protected] / [email protected]

For Genstar
Chris Tofalli
Chris Tofalli Public Relations
914-834-4334
[email protected] 

For FTV Capital
Josh Hess
Prosek Partners on behalf of FTV Capital
646-818-9291
[email protected]

SOURCE Docupace Technologies, LLC

With this latest raise, the company behind the world’s first fully electric, driver-optional, smart tractor cements its position as a leader in the space 

LIVERMORE, Calif., July 22, 2024 — Monarch Tractor, creator of the MK-V, the world’s first fully electric, driver-optional smart tractor and Wingspan Ag Intelligence (WingspanAI) farm management platform, has today announced a history-making $133 million Series C, making it the largest funding raising round in agricultural robotics history.

Monarch has quickly become a powerhouse within the agricultural space as an off-road electric vehicles (EV) and autonomous vehicles (AV) category leader. To date, the company has raised over $220 million to enable clean, efficient, and economically viable solutions as well as expanded into various agricultural markets such as vineyards, dairy, berries, orchards, and land management across 12 states and three countries. Furthermore, in just the last two years alone they have been recognized as an influential force in farming at national and international levels via accolades, including Forbes Next Billion-Dollar Startups, CNBC Disruptor 50, TIME Best Inventions, and Fast Company World’s Most Innovative Companies.

The Series C funds will support the further development of Monarch’s cutting-edge AI product offering, expansion of their operational footprint domestically and globally, while enabling the company’s path to profitability.

Funding was co-led by global impact investor Astanor and HH-CTBC Partnership, L.P., with additional support from prominent investors, including At One Ventures, PMV and The Welvaartsfonds.

Monarch’s mission with farmer success at the center

Founded on the belief that food security only exists with planet sustainability and farmer profitability, Monarch has been at the forefront of the critical transition to renewably powered and more profitable farming ecosystems, which ultimately empowers farmers worldwide.

In the United States, farm profitability has steadily declined over the past decade, with the sharpest decline in industry history occurring in 2023. Given the nascent nature of technology in agriculture, the sector is ripe with untapped growth potential across automation, digital technologies and AI efficiencies, with Monarch at the forefront of this disruption and technological advancement.

“Driven by artificial intelligence (AI) and electrification, agriculture has arrived as the next frontier for the energy transition and sustainability movement,” said Praveen Penmetsa, CEO and co-founder of Monarch Tractor. “Agriculture is our planet’s most important and overlooked sector, and those in the industry have faced significant challenges, including farm profitability, labor shortages, worker safety, government headwinds, data availability, and scrutiny for sustainability demands. Monarch’s application of AI and introduction of a smart, electric platform will deliver robust social, economic, and environmental returns to farmers.”

AI continues to revolutionize farming machinery

Tractors have been the center of all farm operations for several decades. Yet, they’ve been underutilized as a hub for robotics innovation and farmer payback.

In December 2022, Monarch released the world’s first fully electric, driver-optional, smart tractor, the MK-V, to combat profit challenges, address sustainability demands, and revive agriculture innovation. Since then, the deployment of more than 400 MK-V’s have helped; resulting in more than 850 tonnes of harmful CO2 emissions offset across 42,000 hours of tractor operations.

Monarch’s WingspanAI app is equipping farmers with unprecedented access to on-farm data, integrating a farm management system, vehicle position tracking, crop image collection, and automated operations planning into one platform. The continual development of product solutions, including the introduction of new AI capabilities, will be the driving force in closing the industry’s profit gap.

This funding round will support the expansion of Monarch’s digital solutions and AI applications, including the development of Autodrive, Monarch’s autonomous operations feature, for new global markets and crop sectors.

For more information on Monarch Tractor, visit: www.monarchtractor.com/

About Monarch Tractor

Monarch Tractor’s MK-V is the world’s first fully electric, driver-optional, smart tractor that combines electrification, automation, machine learning, and data analysis to enhance farmer’s existing operations, cut overhead costs, reduce emissions and increase labor productivity and safety. Monarch Tractor is committed to elevating farming practices to enable clean, efficient, and economically viable solutions for today’s farmers and the generations of farmers to come. Operating in more than five continents, Monarch Tractor serves vineyards, orchards, blueberries, dairy, and land management sectors. With cutting-edge technology and a global presence, Monarch is delivering meaningful change for the future of farming. For more information, visit www.monarchtractor.com.

Monarch Tractor Media Contact:

Sling & Stone l [email protected]

SOURCE Monarch Tractor

Cowboy Clean Fuels Announces Final Close of $13 Million Series B to Commercialize Technology for Scalable, Simultaneous Production of Renewable Natural Gas and Sequestration of Carbon Dioxide.

DENVER and GILLETTE, Wyo., July 22, 2024 — Cowboy Clean Fuels (CCF), an advanced climate tech and energy transition company, is pleased to announce the successful closing of approximately $13 million in Series B equity financing. This funding will be pivotal in commercializing its groundbreaking technology for the simultaneous production of renewable natural gas (RNG) and permanent sequestration of carbon dioxide, presenting a significant opportunity for investors in the growing renewable energy and carbon markets.

Founded in 2020, CCF utilizes depleted Coal Bed Methane (CBM) wells and infrastructure in Wyoming’s Powder River Basin to generate carbon-negative RNG from agricultural byproducts. These byproducts are converted into CO2 and renewable methane through a biogenic process in deep, geologic coal formations. The commercialization of this technology, termed “Biomass with Carbon Removal and Storage, plus Renewable Natural Gas (BiCRS+RNG),” represents a scalable, capital-efficient solution in the renewable energy sector.

The Series B financing round was led by Houston-based Machan Investments, the family office of former energy executive Dan Dinges. Cowboy Clean Fuels was advised in the transaction by Syren Capital. Combined with $7.8 million in Energy Matching Funds (EMF) from the Wyoming Energy Authority (WEA), this capital will support the development of CCF’s first commercial project in Wyoming, the Triangle Unit Renewable Energy and Carbon Capture and Storage (TRECCS) Project.

With approval for a Notice to Inject from the Wyoming Department of Environmental Quality (WDEQ), the TRECCS Project began commercial operations in early June. Since then, it has injected 15,000 barrels of mixed feedstock for microbial conversion to methane and carbon dioxide. This marks a significant milestone as CCF advances towards full commercialization.

Investment Potential in Renewable Natural Gas (RNG) and Carbon Dioxide Removal (CDR) Markets

RNG is one of the fastest-growing renewable energy markets in the United States, offering a cost-effective decarbonization pathway for various industrial processes. CCF’s first project is expected to produce approximately 600 million cubic feet of pipeline-ready RNG annually at full scale, providing a lucrative opportunity for investors. The carbon dioxide removal market is also rapidly gaining traction, with increasing recognition as crucial for achieving Net Zero goals. CCF’s technology, developed by co-founder Dr. Michael Urynowicz and licensed from the University of Wyoming School of Energy Resources, is ready for commercial deployment and can sequester approximately 180,000 metric tons of CO2e per year at scale.

Strategic Advantages and Market Differentiation

CCF’s technology addresses the saturation in the conventional RNG market, dominated by anaerobic digesters at dairy farms, by offering a more scalable, cost-effective, and faster-to-deploy solution. The company’s technology not only generates renewable energy but also permanently sequesters carbon dioxide through a physical adsorption process that remains stable under naturally occurring hydrostatic pressure, ensuring long-term carbon removal.

Key Investment Highlights:

1. The approximately $20 million in capital raised positions CCF to reach full scale by the end of 2025, potentially making it one of the largest global producers of both RNG and CDR credits.
2. The TRECCS Project showcases innovative technology developed in Wyoming, leveraging existing assets and positioning the state as a leader in renewable natural gas and carbon capture, utilization, and storage (CCUS).
3. Scaling CCF’s technology throughout the Powder River Basin could make Wyoming the largest producing state for RNG and sequestered CO2, benefiting the state’s energy and agricultural industries, economy, and citizens.

Ryan Waddington, CEO of CCF, stated, “We are incredibly pleased to have secured investment from some of the smartest and most experienced energy entrepreneurs, operators, and investors in the country. This capital, along with the WEA matching funds, will enable us to fully commercialize the BiCRS+RNG process and realize the technology vision behind it, which is nearly twenty years in the making.”

Susan Vick Dinges, Syren Capital, commented, “Cowboy’s technology is coming to market at a critical juncture in both RNG and CDR markets. Demand for RNG is growing beyond the traditional transportation fuel markets, however traditional RNG supply volumes are constrained and require higher end buyer prices to Cowboy. Similarly, demand for high quality, long duration carbon removal is exploding, but at high costs – emerging solutions like DAC are not yet ready to deliver. The investor community recognized that Cowboy is ready to carve out a leadership position in both sectors by delivering both RNG and CDR attributes and credits to market in the near term – and with greater scale than the competitive landscape.”

Dan Dinges, Chairman of Machan Investments, added, “We have been impressed with the company’s continued progress since our initial investment in 2022 in all areas of regulatory, compliance, operations, commercial and refining development costs to add value to offtake buyers. Machan is excited to lead this financing and bullishly support Cowboy’s commercialization and scale up.”

David Kailbourne, CEO of REV LNG, LLC and Renewable Operations Company, LLC, also remarked, “I am looking forward to joining the Cowboy Board, and guiding the management team as they work to achieve the next technology, commercial and market milestones for the company. Cowboy’s leadership has done an exceptional job positioning the company for success on every dimension – commercially, they are unparalleled in scale to deliver RNG and sequester carbon in the growing voluntary markets.”

Learn more at https://www.cowboycleanfuels.com.

SOURCE Cowboy Clean Fuels

Dalmore Group’s  has more then $3.6B live reg A+ offerings

NEW YORK, July 22, 2024 — Onassis Holding Corp (OTC: ONSS), a wellness and biotech focused holding company, announced the launch of a Regulation A+ financing round. This follows an agreement with Dalmore Group.

Reg A+ provides a streamlined process for companies to raise up to $75 million annually from the public. In aligning with Dalmore Group, Onassis looks to leverage the investment bank’s prowess in capital raising through Regulations A+, CF, and D. Since 2021, Dalmore has on-boarded over 270 Reg A+ issuers, establishing itself as a leader in Reg A+ financing services.

With over 16 years of experience and deep relationships in multiple financial markets, Dalmore provides strategic partnerships with experts in marketing and PR, syndication partnerships with several Reg A+ marketplace platform distribution partners, and secondary trading solutions for their Reg A+ issuers.

About Onassis Holdings Corp
Onassis Holdings Corp is a wellness and biotech holding company, specializing in healthcare, technology, and the epigenetic reprogramming for rejuvnation.

Forward-Looking Statements
Statements that are not historical or current facts are “forward-looking statements” under the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause the Company’s actual results to differ materially from historical or future results. “Believes,” “should,” “intends,” “will,” or “plans” are considered uncertain and forward-looking statements.

Logo – https://mma.prnewswire.com/media/1708529/Onassis_Holdings_Corp_Logo.jpg

For more information about Onassis: 
Onassis Holdings Corp.
+1-516-620-6794
[email protected]
www.ananda-labs.bio

SOURCE Onassis Holdings Corp

SÃO PAULO, July 19, 2024 — CTA Smart, a leading technology company in the fuel sector, has secured a US$ 3 million investment in a new funding round to boost its international growth. Led by Invisto and Indicator Capital, this investment will support CTA Smart’s expansion into the American market and lay the groundwork for global outreach.

Investment Details Indicator Capital, the largest early-stage venture capital firm in Latin America specializing in Internet of Things (IoT), and Invisto, a Southern Brazilian VC firm, are spearheading the investment. Invisto contributed US$ 2 million, while Indicator Capital added US$ 1 million. CTA Smart had previously received US$ 1 million from the Indicator 2 IoT fund in October 2021, with total investments now reaching approximately US$ 3 million.

Growth and Expansion CTA Smart’s consistent financial and commercial growth, particularly in North America, influenced the investment decision. The company’s operational strength is shown by its active fueling points, exceeding 3,000 in Brazil and over 400 in the United States over the past 18 months. The startup manages more than 2.5 billion liters of diesel annually.

Agile Management Platform Headquartered in Brazil, CTA Smart utilizes intelligent systems technology for fleet fueling, operating on a Software as a Service (SaaS) model. The platform offers robust, remote installation for fuel management across various industries globally, previously available only to large enterprises. Fuel is a significant cost for sectors such as transportation, mining, construction, and forestry. CTA Smart’s real-time, cloud-based management reduces waste and deviations, lowering operational costs while enhancing productivity, profitability, and competitiveness.

American Market Potential Bruno Lopes, CEO of CTA Smart, highlighted the company’s partnerships with major distributors in Brazil and TRRs, improving fuel delivery logistics and customer relations. Marcelo Wolowski, founder and CEO of Invisto, expressed enthusiasm about CTA Smart’s promising traction in the American market, serving as a gateway to the global market.

Global Reach CTA Smart’s international brand, Link2Pump, led by CEO Filipe Borges, has grown over 100% annually for two years and operates in seven countries, including Argentina, Uruguay, Paraguay, the Dominican Republic, Mexico, Canada, and the UAE. The technology serves over 40 U.S. states, attracting large-scale clients. Borges noted the company’s readinors with internals for the next step toward becoming a global entity.

About CTA Smart | Link2Pump Founded in 2012, CTA Smart specializes in fuel management, fleet management, and supply control. Based in Porto Alegre-RS, Brazil, and Miami, USA, the company prides itself on simplicity and adaptability, addressing customer needs across various sectl diesel consumption. For more information, visit www.link2pump.com

SOURCE CTA Smart

In an investment round led by 360 ONE Asset, Aereo closed its Series B funding, announcing plans for global expansion

BENGALURU, India, July 19, 2024 — Aereo, India’s leading drone-based business intelligence provider, has successfully closed a $15 million Series B funding round led by 360 ONE Asset. The round saw participation from long-standing investors StartupXseed Ventures and Navam Capital.

Aereo delivers business intelligence solutions to help manage large capital assets using proprietary drones and an AI-powered data analytics platform. Their sector-specific solutions cater to mining, infrastructure, urban and rural development, land records, and other industries translating into a 400% revenue growth in the last two years and market dominance.

Vipul Singh, co-founder and CEO of Aereo, stated, “This funding milestone enables us to expand our aerial intelligence solutions for capital asset management. With our proprietary drone tech and 360 ONE Asset’s partnership, we aim to revolutionize this $10 billion industry and create a global footprint.”

Suhas Banshiwala, co-founder and CTO of Aereo, stated, “Our vision is to continuously innovate drone manufacturing and data analytics for the greater good. We are excited about the confidence our customers and shareholders have shown and are gearing up for an orbital shift.”

Aereo has been recognized by the Asian Infrastructure Investment Bank (AIIB) as one of the top three infra-tech organizations. As a technology partner for Coal India Limited’s Digicoal initiative, Aereo provides critical business intelligence for some of the world’s largest coal mines for improving productivity, efficiency, safety, and environmental compliance. It has also been empanelled with Tata Steel since 2019, aiding the digitalisation of over 27 critical mines and stockyards. Over the past three years, Aereo has achieved significant milestones, including mapping over 45,000 villages under the SVAMITVA scheme and covering more than 50,000 sq. km of land area for the Digital India Land Record Modernization Program (DILRMP).

The Series B investment serves as a powerful catalyst for Aereo’s growth, with a key focus on automation. Their AI-powered drone data analytics platform is set to revolutionise automation and digitisation. With strategic partnerships, R&D, and new product development, Aereo is ready to lead the global drone solutions sector.

Karan Ahuja, Fund Manager at 360 ONE, remarked, “We’re thrilled with the momentum in the commercial drone tech sector in India. Our partnership with Aereo reflects our belief in their cutting-edge innovations, and we’re excited for their solutions to go global.”

Ravi Thakur, Co-Founding Partner at StartupXseed, added, “Aereo has been a trailblazer from the start, delivering exceptional solutions and building the drone ecosystem. We’re excited to support them in their next major growth phase.”

About Aereo:

Founded in 2013 at IIT Kanpur, Aereo (formerly Aarav Unmanned Systems) is India’s premier drone-based business intelligence provider, serving industries such as mining, infrastructure, urban and rural development, land records, and more. Aereo is backed by notable early-stage deep tech investors like Auxano Capital, KARSEMVEN, 3one4 Capital, GrowX Ventures, 500 Startups, and Ashok Atluri (MD of Zen Technologies).

Photo: https://mma.prnewswire.com/media/2464648/Aereo.jpg
Logo: https://mma.prnewswire.com/media/2464649/Aereo_Logo.jpg

SOURCE Aereo

Company awarded government project agreement to onshore key pharmaceutical supply chains, alongside strategic investment from In-Q-Tel and Echo

MENLO PARK, Calif., July 19, 2024 /PRNewswire/ — Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced $17 million in new funding via a government project agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), alongside matching support from new strategic investors. The combined funding will support onshoring the production of critical pharmaceutical ingredients to the U.S. and accelerating the company’s commercialization strategy. The funding includes a non-dilutive two-year project agreement up to $11 million through the BioMaP Consortium and additional investment from In-Q-Tel, Inc. (IQT), Echo Investment Capital (Echo), and several existing investors, including Viking Global Investors.

“Biotechnology has a critical role to play in U.S. national and economic security,” said Dr. Christina Smolke, Antheia CEO and co-founder. “With the support of both the public and private sectors, we can leverage this technology to bolster essential medicine production in the U.S., with an agile, scalable biomanufacturing approach that leapfrogs existing pharmaceutical manufacturing practices.”

The BioMaP-Consortium is a multiple-purpose acquisition vehicle supporting the Biomedical Advanced Research and Development Authority (BARDA) and is composed of pharmaceutical, medical, academic, and scientific organizations. This project has been funded in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response (ASPR); Office of Industrial Base Manufacturing and Supply Chain (IBMSC), under OT number #75A50123D00003.

The BioMaP-Consortium aims to meet the U.S. public health preparedness and response requirements by expanding the industrial and manufacturing base for medical countermeasures. As part of the BioMaP-Consortium award, Antheia will demonstrate the domestic production of three critical pharmaceutical ingredients at population scale using advanced biomanufacturing processes. 

In addition to the BioMaP-Consortium project agreement, Antheia brought in matching support from new strategic investors – including IQT and Echo – that represent the intersection of innovation, national security, and domestic manufacturing. IQT connects cutting edge innovation from the private sector to the U.S. government and its allies to advance national security in the 21st century. Echo is a multi-strategy investment firm that connects overlooked domestic resources and infrastructure with world-class founders, ideas, and capital to generate exceptional financial and social returns.

“The U.S. is a leader in biomanufacturing, synthetic biology, and computational biology, but there is more we must do to scale these advanced technologies to solve global problems like essential medicine shortages,” said Eugene Chiu, Senior Partner, IQT. “We are excited to support Antheia in advancing the U.S. bioeconomy and building resilient pharmaceutical supply chains.”

“Antheia’s disruptive innovation is dramatically changing the outlook for security and resiliency of our biopharmaceutical supply chains,” said Christian Kanady, Founding Partner & CEO, Echo. “We are proud to partner in advancing Antheia’s groundbreaking technologies and importantly renewing the domestic bioeconomy in the process.” 

Today’s financing news comes on the heels of significant 2024 momentum, including the company’s validated process for its first product , thebaine, and the opportunity to host U.S. Secretary of State, Antony J. Blinken at its labs for a discussion on the importance of a robust domestic bioeconomy. Antheia continues to deliver on its commercial strategy and plans to ship its first orders to customers later this year. 

About Antheia 
Antheia is the next-generation pharmaceutical ingredient producer transforming essential  medicine supply chains to end drug shortages. Using its novel whole-cell engineering approach, Antheia’s biomanufacturing platform enables the reconstruction of biosynthetic pathways of unprecedented complexity in yeast cells and the scaling of fermentation processes to  commercial levels. This highly flexible approach enables on-demand, agile, and resilient biomanufacturing of critical pharmaceutical ingredients, replacing legacy approaches that cannot support the needs of modern healthcare. For more information, visit www.antheia.bio. 

MEDIA CONTACT:
Mission North for Antheia
[email protected]

SOURCE Antheia

Nate Forster Will Advance Expertise Research by Building a Research Tool and Educational Resource for Business Leaders

GREENWICH, Conn. , July 19, 2024 — O’Shaughnessy Ventures LLC (“OSV”), an investment firm that empowers creators, has awarded an O’Shaughnessy Fellowship to Nate Forster, a researcher, executive coach and operations expert based in Canada.

Together with his team (Bhaumik Patel and Anirudh Kannan), Forster will build a research resource that enables business leaders to scale their companies by better understanding the expertise of their top performers. He will also develop a software tool that dramatically improves the speed and ease of conducting expertise research.

Forster has previously worked closely with the renowned CEO and executive coach Matt Mochary, including as Mochary’s chief of staff. In this role, Forster worked with and built knowledge products for founders and CEOs of some of the United States’ best-known companies. These experiences enabled him to study how experts learn and operate and taught him that much of the world’s most important knowledge is tacitly held.

OSV’s founder and CEO, Jim O’Shaughnessy, commented, “Regardless of your role or occupation, there are huge benefits to studying and learning from experts across disciplines. However, much of their knowledge remains hidden. Nate’s extensive experience working with experts and studying expertise makes him the perfect person to lead this project, and we are delighted to be able to support him over the coming months.”

“I’m truly humbled and honored to be part of the program,” said Forster. “My career was jumpstarted by the work of Jim and Patrick O’Shaughnessy, so it’s an incredible feeling to be recognized with a Fellowship.”

About the Fellowship Program

OSV launched the O’Shaughnessy Fellowships in 2023. It is a one-year program for ambitious people who want to build something great. Fellows receive a $100,000 grant and access to OSV’s network of founders, investors and experts to support them in bringing their projects to life. More information about OSV’s Fellows is available on its website.

In 2024, OSV will award ten $100,000 Fellowships. Applicants for the Fellowships will also be considered for its sister program, the O’Shaughnessy Grants. Under this program, OSV will make twenty additional $10,000 grants to promising creators, who will also be provided with access to OSV’s network.

Applications for the 2024 Fellowships are now closed and will reopen on January 1, 2025. Creators interested in learning more can visit OSV’s website.

About O’Shaughnessy Ventures

OSV is a creative investment firm that empowers and inspires creators to bring their ideas to life. Founded by Jim O’Shaughnessy, a pioneer in quantitative investing, founder of O’Shaughnessy Asset Management, and author of four books on investing, OSV aims to provide financial support and to partner in growing the next life-changing creative ideas.

OSV combines Jim’s deeply rooted interest in all things art, science, investing, and tech with his long-held desire to establish scenarios designed to help promising creators and their inspiring ideas succeed, regardless of age, location, job history, or level of education. For more information, visit https://www.osv.llc.

Media Contact:
Ena Gong
O’Shaughnessy Ventures LLC
(917) 355-7420
[email protected] 

SOURCE O’Shaughnessy Ventures